Silver ciprofloxacin (CIPAG): a multitargeted metallodrug in the development of breast cancer therapy
JBIC Journal of Biological Inorganic Chemistry · 06.04.2024 · 29 (2) · 177-186
DOI: 10.1007/s00775-024-02048-y ↗Kurz gefasst
Fachartikel in der Zeitschrift JBIC Journal of Biological Inorganic Chemistry, online erschienen am 06.04.2024. Verfasst von Christina N Banti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Ioannina, 45110, Ioannina, Greece. cbanti@uoi.gr. Hauptthemen laut MEDLINE: Ciprofloxacin, Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Human Resources Development, Education and Lifelong Learning 2014-2020.
Abstract (Originalsprache)
The anti-proliferative activity of the known metalloantibiotic {[Ag(CIPH) 2 ]NO 3 ∙0.75MeOH∙1.2H 2 O} ( CIPAG ) (CIPH = ciprofloxacin) against the human breast adenocarcinoma cancer cells MCF-7 (hormone dependent (HD)) and MDA-MB-231 (hormone independent (HI)) is evaluated. The in vitro toxicity and genotoxicity of the metalloantibiotic were estimated toward fetal lung fibroblast (MRC-5) cells. The molecular mechanism of the CIPAG activity against MCF-7 cells was clarified by the (i) cell morphology, (ii) cell cycle arrest, (iii) mitochondrial membrane permeabilization, and (iv) by the assessment of the possible differential effect of CIPAG on estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) transcriptional activation, applying luciferase reporter gene assay. Moreover, the ex vivo mechanism of CIPAG was clarified by its binding affinity toward calf thymus (CT-DNA). Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Ioannina, 45110, Ioannina, Greece. cbanti@uoi.gr.
- Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
- Department of Life Sciences, The School of Sciences, European University Cyprus, Nicosia, Cyprus.
- Department of Chemistry, University of Ioannina, 45110, Ioannina, Greece. shadjika@uoi.gr.
- Institute of Materials Science and Computing, University Research Centre of Ioannina (URCI), Ioannina, Greece. shadjika@uoi.gr.
Förderung
- Human Resources Development, Education and Lifelong Learning 2014-2020
Zitieren
APA
Banti, C. N., Kalousi, F. D., Psarra, A. G., Moushi, E. E., Leonidas, D. D., & Hadjikakou, S. K. (2024). Silver ciprofloxacin (CIPAG): a multitargeted metallodrug in the development of breast cancer therapy. JBIC Journal of Biological Inorganic Chemistry, 29(2), 177-186. https://doi.org/10.1007/s00775-024-02048-y
Vancouver
Banti CN, Kalousi FD, Psarra AG, Moushi EE, Leonidas DD, Hadjikakou SK. Silver ciprofloxacin (CIPAG): a multitargeted metallodrug in the development of breast cancer therapy. JBIC Journal of Biological Inorganic Chemistry. 2024;29(2):177-186. doi:10.1007/s00775-024-02048-y
BibTeX
@article{Banti2024,
author = {Banti, Christina N and Kalousi, Foteini D and Psarra, Anna-Maria G and Moushi, Eleni E and Leonidas, Demetres D and Hadjikakou, Sotiris K},
title = {Silver ciprofloxacin (CIPAG): a multitargeted metallodrug in the development of breast cancer therapy},
journal = {JBIC Journal of Biological Inorganic Chemistry},
year = {2024},
volume = {29},
number = {2},
pages = {177--186},
doi = {10.1007/s00775-024-02048-y}
}
EUVIMED